Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
147.4 USD | -0.01% |
|
+2.90% | +11.91% |
Jul. 09 | RBC Cuts Price Target on Neurocrine Biosciences to $136 From $141, Keeps Sector Perform Rating | MT |
Jul. 03 | ANALYST RECOMMENDATIONS : Alphabet, Nike, Nvidia, Tesla, Starbucks... | ![]() |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.91% | 14.84B | |
+20.17% | 126B | |
+24.67% | 118B | |
+23.96% | 27.87B | |
-17.74% | 20.95B | |
-15.22% | 16.92B | |
-15.21% | 16.18B | |
-47.10% | 14.79B | |
+54.50% | 14.08B | |
+151.63% | 12.57B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Transcript : Neurocrine Biosciences, Inc. - Special Call